Table 1 The proportion of alternative splicing variants in selected non-tumour tissues.

From: Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues

ASV

Female internal genital tract NT

(N = 31) (%)

Kidney NT

(N = 31) (%)

Pancreas NT

(N = 7) (%)

Prostate NT

(N = 35) (%)

Large intestine NT

(N = 42) (%)

3p

29.7

28.2

30.2

29.1

33.5

Δ7

1.9

1.7

1.9

1.5

1.7

Δ7–8

1.1

1.0

1.7

0.8

1.2

Δ8

3.2

3.8

6.9

2.3

6.7

  1. Each value represents the percentage of the overall HNF1B mRNA expression (100%; calculated as the sum of canonical exon 3 and 3p variants). N number of samples, NT non-tumour tissue.